Evaluation of the safety and neuroprotective properties of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo investigation - Poll - MDSpire

Evaluation of the safety and neuroprotective properties of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo investigation

  • By

  • Ana-Cristina Almansa-García

  • Angela Armento

  • Bowen Cao

  • Anne-Sophie Petremann-Dumé

  • Stefano Salmaso

  • Paolo Caliceti

  • Cristine Henes

  • Sylvie Bolz

  • Ellen Kilger

  • Daniela Süsskind

  • Marius Ueffing

  • Blanca Arango-Gonzalez

  • January 10, 2026

  • 0 min

Share

Original Source(s)

Evaluation of the safety and neuroprotective properties of the VCP inhibitor ML240 in large-animal and human retinal explants: a preclinical ex vivo investigation

  • by Ana-Cristina Almansa-García, Angela Armento, Bowen Cao, Anne-Sophie Petremann-Dumé, Stefano Salmaso, Paolo Caliceti, Cristine Henes, Sylvie Bolz, Ellen Kilger, Daniela Süsskind, Marius Ueffing, Blanca Arango-Gonzalez

  • January 10, 2026

Related Content

Evaluation of Laser Doppler Holography for Assessing Choroidal Blood Flow: A Comprehensive Review of Technical Features, Validation Research, and Clinical Uses

Hospital-Treated Infections Linked to Dementia Risk

Investigators identify 29 conditions associated with dementia risk in nationwide registry analysis.

Single-cell transcriptomic profiling uncovers pathogenic cellular diversity and potential inflammatory markers in the retinas of STZ-induced diabetic mice